Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study
- PMID: 20558392
- PMCID: PMC3329757
- DOI: 10.1001/archneurol.2010.95
Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study
Abstract
Background: Mutations in the parkin gene are the most common genetic cause of early-onset Parkinson disease (PD). Results from a multicenter study of patients with PD systematically sampled by age at onset have not been reported to date.
Objective: To determine risk factors associated with carrying parkin mutations.
Design: Cross-sectional observational study.
Setting: Thirteen movement disorders centers.
Participants: A total of 956 patients with early-onset PD, defined as age at onset younger than 51 years.
Main outcome measures: Presence of heterozygous, homozygous, or compound heterozygous parkin mutations.
Results: Using a previously validated interview, 14.7% of patients reported a family history of PD in a first-degree relative. Sixty-four patients (6.7%) had parkin mutations (3.9% heterozygous, 0.6% homozygous, and 2.2% compound heterozygous). Copy number variation was present in 52.3% of mutation carriers (31.6% of heterozygous, 83.3% of homozygous, and 81.0% of compound heterozygous). Deletions in exons 3 and 4 and 255delA were common among Hispanics (specifically Puerto Ricans). Younger age at onset (<40 years) (odds ratio [OR], 5.0; 95% confidence interval [CI], 2.8-8.8; P = .001), Hispanic race/ethnicity (OR compared with white non-Hispanic race/ethnicity, 2.7; 95% CI, 1.3-5.7; P = .009), and family history of PD in a first-degree relative (OR compared with noncarriers, 2.8; 95% CI, 1.5-5.3; P = .002) were associated with carrying any parkin mutation (heterozygous, homozygous, or compound heterozygous). Hispanic race/ethnicity was associated with carrying a heterozygous mutation (OR compared with white non-Hispanic race/ethnicity, 2.8; 95% CI, 1.1-7.2; P = .03) after adjustment for covariates.
Conclusions: Age at onset, Hispanic race/ethnicity, and family history of PD are associated with carrying any parkin mutation (heterozygous, homozygous, or compound heterozygous) and heterozygous mutations alone. The increased odds of carrying a parkin mutation among Hispanics warrants further study.
Conflict of interest statement
Disclosure: The authors report no conflicts of interest.
Similar articles
-
Case-control study of the parkin gene in early-onset Parkinson disease.Arch Neurol. 2006 Apr;63(4):548-52. doi: 10.1001/archneur.63.4.548. Arch Neurol. 2006. PMID: 16606767
-
Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study.Arch Neurol. 2006 Jun;63(6):826-32. doi: 10.1001/archneur.63.6.826. Arch Neurol. 2006. PMID: 16769863
-
Mutation screening and association analysis of the parkin gene in Parkinson's disease patients from South-West China.Eur Neurol. 2003;49(2):85-9. doi: 10.1159/000068505. Eur Neurol. 2003. PMID: 12584415
-
Distribution, type, and origin of Parkin mutations: review and case studies.Mov Disord. 2004 Oct;19(10):1146-57. doi: 10.1002/mds.20234. Mov Disord. 2004. PMID: 15390068 Review.
-
[Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].Rinsho Shinkeigaku. 2004 Apr-May;44(4-5):241-62. Rinsho Shinkeigaku. 2004. PMID: 15287506 Review. Japanese.
Cited by
-
Parkin regulates amino acid homeostasis at mitochondria-lysosome (M/L) contact sites in Parkinson's disease.Sci Adv. 2023 Jul 21;9(29):eadh3347. doi: 10.1126/sciadv.adh3347. Epub 2023 Jul 19. Sci Adv. 2023. PMID: 37467322 Free PMC article.
-
Genetic analysis of PARK2 and PINK1 genes in Brazilian patients with early-onset Parkinson's disease.Dis Markers. 2013;35(3):181-5. doi: 10.1155/2013/597158. Epub 2013 Aug 14. Dis Markers. 2013. PMID: 24167364 Free PMC article.
-
Emerging roles of mitochondrial functions and epigenetic changes in the modulation of stem cell fate.Cell Mol Life Sci. 2024 Jan 12;81(1):26. doi: 10.1007/s00018-023-05070-6. Cell Mol Life Sci. 2024. PMID: 38212548 Free PMC article. Review.
-
Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.Neurology. 2012 May 1;78(18):1434-40. doi: 10.1212/WNL.0b013e318253d54b. Epub 2012 Mar 21. Neurology. 2012. PMID: 22442429 Free PMC article.
-
Hexaconazole exposure may lead to Parkinson via disrupting glucocerebrosidase and parkin: molecular interaction, dynamics, MMPBSA and DFT based in-silico predictive toxicology.Toxicol Res (Camb). 2024 Feb 13;13(1):tfae018. doi: 10.1093/toxres/tfae018. eCollection 2024 Feb. Toxicol Res (Camb). 2024. PMID: 38496321 Free PMC article.
References
-
- Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998 Apr 9;392(6676):605–608. - PubMed
-
- Hedrich K, Eskelson C, Wilmot B, et al. Distribution, type, and origin of Parkin mutations: Review and case studies. Mov Disord. 2004 Oct;19(10):1146–1157. - PubMed
-
- Lucking CB, Durr A, Bonifati V, et al. Association between early-onset Parkinson’s disease and mutations in the parkin gene. French Parkinson’s Disease Genetics Study Group. N Engl J Med. 2000 May 25;342(21):1560–1567. - PubMed
-
- Hedrich K, Marder K, Harris J, et al. Evaluation of 50 probands with early-onset Parkinson’s disease for Parkin mutations. Neurology. 2002 Apr 23;58(8):1239–1246. - PubMed
-
- Abbas N, Lucking CB, Ricard S, et al. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson’s Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson’s Disease. Hum Mol Genet. 1999 Apr;8(4):567–574. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical